1–4 of 4 results for Glenn J. Jaffe
Baseline Characteristics in the Phase 2 GOLDEN Study of IONIS-FB-LRx, an Investigational Antisense Oligonucleotide Designed to Treat AMD-Associated Geographic Atrophy
Glenn J. Jaffe, MD
Annual Meeting Talks
2022
How Do I Decide to Treat Patients with Geographic Atrophy?
Updates from the Field
2024
Imaging Pearls in AMD
Netan Choudhry, MD, FRCS(C) FASRS
Member Podcasts
Confirmatory 1-Year Study Results of an Injectable Fluocinolone Acetonide Intravitreal Insert to Treat Noninfectious Posterior Segment Uveitis
2018